BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B

Oxyfedrine

A drug used in the treatment of angina pectoris, heart failure, conduction defects, and myocardial infarction. It is a partial agonist at beta adrenergic receptors and acts as a coronary vasodilator and cardiotonic agent.

144+ PubMed studies analyzed · 6 RCTs · Evidence Score: 45.8

Research Domains

Oxyfedrine has been studied across 14 research domains including ❤️ Cardiovascular, 🧠 Focus & Attention, 🫁 Respiratory, 🔬 Inflammation, ⚡ Energy & Fatigue. The primary research focus is ❤️ Cardiovascular with 42% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Oxyfedrine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Penbutolol
5 shared targets
Thiethylperazine
9 shared targets
Nebivolol
9 shared targets
difluorobenztropine
4 shared targets
vanoxerine
4 shared targets
atomoxetine
4 shared targets
vilazodone
4 shared targets
amitifadine
4 shared targets
bupropion
4 shared targets
Dihydroergocryptine
4 shared targets
Loading evidence profile...

This evidence profile for Oxyfedrine is generated deterministically from 144 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.